Inventor
FRETZEN ANGELIKA
US21 patents
⚠️ This page may combine multiple inventors who share the name “FRETZEN ANGELIKA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IRONWOOD PHARMACEUTICALS INC
8 patentsUS7910546B2Mar 22, 2011
Methods and compositions for the treatment of gastrointestinal disorders
IRONWOOD PHARMACEUTICALS INC29 citations92
US7772188B2Aug 10, 2010
Methods and compositions for the treatment of gastrointestinal disorders
IRONWOOD PHARMACEUTICALS INC31 citations91
US9139564B2Sep 22, 2015
2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulators
IRONWOOD PHARMACEUTICALS INC15 citations83
US9309235B2Apr 12, 2016
SGC stimulators
IRONWOOD PHARMACEUTICALS INC12 citations81
US8946158B2Feb 3, 2015
Treatments of gastrointestinal disorders
IRONWOOD PHARMACEUTICALS INC5 citations70
US10189809B2Jan 29, 2019
SGC stimulators
IRONWOOD PHARMACEUTICALS INC0 citations51
US10702576B2Jul 7, 2020
Stable formulations of linaclotide
IRONWOOD PHARMACEUTICALS INC0 citations49
US10675325B2Jun 9, 2020
Stable formulations of linaclotide
IRONWOOD PHARMACEUTICALS INC0 citations49
CURRIE MARK G
5 patentsUS8507447B2Aug 13, 2013
Treatments for gastrointestinal disorders
CURRIE MARK G12 citations82
US8735360B2May 27, 2014
Treatments for gastrointestinal disorders
CURRIE MARK G5 citations71
US9617305B2Apr 11, 2017
Treatments for gastrointestinal disorders
CURRIE MARK G1 citations50
US9650417B2May 16, 2017
Treatments for gastrointestinal disorders
CURRIE MARK G0 citations40
US9527887B2Dec 27, 2016
Treatments for gastrointestinal disorders
CURRIE MARK G0 citations39
FRETZEN ANGELIKA
3 patentsUS8802628B2Aug 12, 2014
Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration
FRETZEN ANGELIKA7 citations79
US8748573B2Jun 10, 2014
Formulations comprising linaclotide
FRETZEN ANGELIKA8 citations79
US8933030B2Jan 13, 2015
Treatments for gastrointestinal disorders
FRETZEN ANGELIKA2 citations60